These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 26632308)

  • 21. Coverage of human papillomavirus vaccination during the first year of its introduction in Spain.
    Limia A; Pachón I
    Euro Surveill; 2011 May; 16(21):. PubMed ID: 21632017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza and pneumococcal vaccine coverage among a random sample of hospitalised persons aged 65 years or more, Victoria.
    Andrews RM; Skull SA; Byrnes GB; Campbell DA; Turner JL; McIntyre PB; Kelly HA
    Commun Dis Intell Q Rep; 2005; 29(3):283-8. PubMed ID: 16220865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of social determinants on immunization programs.
    Glatman-Freedman A; Nichols K
    Hum Vaccin Immunother; 2012 Mar; 8(3):293-301. PubMed ID: 22327490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community-centered education improves vaccination rates in children from low-income households.
    Suryadevara M; Bonville CA; Ferraioli F; Domachowske JB
    Pediatrics; 2013 Aug; 132(2):319-25. PubMed ID: 23837177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decentralization and public services: the case of immunization.
    Khaleghian P
    Soc Sci Med; 2004 Jul; 59(1):163-83. PubMed ID: 15087152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are expensive vaccines the best investment in low-income and middle-income countries?
    Simonsen L; van Wijhe M; Taylor R
    Lancet Glob Health; 2019 May; 7(5):e548-e549. PubMed ID: 31000121
    [No Abstract]   [Full Text] [Related]  

  • 27. Comment on: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".
    Gandjour A
    Pharmacoeconomics; 2014 Dec; 32(12):1245-6. PubMed ID: 25253682
    [No Abstract]   [Full Text] [Related]  

  • 28. Authors' reply to Gandjour: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".
    Newall AT; Jit M; Hutubessy R
    Pharmacoeconomics; 2014 Dec; 32(12):1247. PubMed ID: 25374292
    [No Abstract]   [Full Text] [Related]  

  • 29. A conversation with Samuel L. Katz, MD. Interviewed by Stanford T. Shulman.
    Katz SL
    Pediatr Ann; 2012 Aug; 41(8):340. PubMed ID: 22881426
    [No Abstract]   [Full Text] [Related]  

  • 30. Comment on: Interventions to improve early detection of childhood cancer in low- and middle-income countries: A systematic review- Experience of time to diagnosis of malignancies in children in Haiti.
    Gassant PY; Caniza MA
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29011. PubMed ID: 33720511
    [No Abstract]   [Full Text] [Related]  

  • 31. Why are vaccination rates lower in low and middle income countries, and what can we do about it?
    Reza HM; Agarwal V; Sultana F; Bari R; Mobarak AM
    BMJ; 2022 Jul; 378():e069506. PubMed ID: 35830982
    [No Abstract]   [Full Text] [Related]  

  • 32. Improving Birth Outcomes in Low- and Middle-Income Countries.
    Goldenberg RL; McClure EM
    N Engl J Med; 2017 Dec; 377(24):2387-2388. PubMed ID: 29236634
    [No Abstract]   [Full Text] [Related]  

  • 33. Improving Evidence for Implementation of Guideline-Based Care in Low- and Middle-Income Countries.
    Granger CB; Xavier D
    JAMA; 2018 Feb; 319(6):554-556. PubMed ID: 29450511
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhancing Local Resources in Low- and Middle-Income Countries Through Education.
    Yang GP; Wren SM
    JAMA Surg; 2017 Jan; 152(1):73-74. PubMed ID: 27706484
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccines work: a reason for celebration and renewed commitment.
    Cohen AL; Patel MK; Cherian T
    Lancet; 2021 Jan; 397(10272):351-353. PubMed ID: 33516322
    [No Abstract]   [Full Text] [Related]  

  • 36. Improving Cancer Outcomes In Low- and Middle-Income Countries.
    Love RR
    J Glob Oncol; 2019 Nov; 5():1-3. PubMed ID: 31702946
    [No Abstract]   [Full Text] [Related]  

  • 37. Special deliveries for remote families.
    Thornton J
    Nurs Stand; 2015 Apr; 29(34):26-7. PubMed ID: 25902229
    [No Abstract]   [Full Text] [Related]  

  • 38. The rising menace of scholarly black-market: Challenges and solutions for improving research in low- and middle-income countries.
    Memon AR; Rathore FA
    J Pak Med Assoc; 2021 Jun; 71(6):1523-1526. PubMed ID: 34111064
    [No Abstract]   [Full Text] [Related]  

  • 39. Improving the quality of intensive care in middle-income countries.
    Quintairos A; Zampieri FG; Salluh JI
    Lancet Glob Health; 2022 Apr; 10(4):e477-e478. PubMed ID: 35303454
    [No Abstract]   [Full Text] [Related]  

  • 40. Health and education in developing countries.
    Furnass B
    BMJ; 1992 Jul; 305(6846):188. PubMed ID: 1515863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.